Anavex Life Sciences Corp (AVXL)

[mike_dotcom]

News like this usually kills our stock -

BRIEF-Longeveron Announces Positive Top-Line Results For Lomecel-B™ In Its Phase 2A Clinical Trial for Mild Alzheimer'S Treatment
REUTERS 7:14 AM ET 10/5/2023
Symbol Last Price Change
LGVN 2.51down 0 (0%)
QUOTES AS OF 04:00:00 PM ET 10/04/2023
Oct 5 (Reuters) - Longeveron Inc(LGVN):

* LONGEVERON ANNOUNCES POSITIVE TOP-LINE RESULTS FOR LOMECEL-B™ IN ITS CLEAR MIND PHASE 2A CLINICAL TRIAL IN THE TREATMENT OF MILD ALZHEIMER'S DISEASE

* LONGEVERON INC(LGVN) - PRIMARY ENDPOINT OF SAFETY MET ACROSS ALL STUDY GROUPS

* LONGEVERON INC(LGVN) - OTHER DOSES DEMONSTRATED NUMERICAL SLOWING/PREVENTION OF DISEASE WORSENING RELATIVE TO PLACEBO

* LONGEVERON INC(LGVN) - ADDITIONAL BIOMARKER DATA EXPECTED TO BE ANNOUNCED IN COMING WEEKS

* LONGEVERON INC(LGVN) - STATISTICAL SIGNIFICANCE MET FOR SECONDARY ENDPOINT Source text for Eikon: Further company coverage: